Society for Endocrinology - a world-leading authority on hormones

News

Canagliflozin does not increase fracture risk in diabetes patients

02 Jan 2019



Canagliflozin treatment does not increase the risk of fractures in type-2 diabetes patients, according to research published in Annals of Internal Medicine.

MedicalXpress